Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?

AUTOR(ES)

Rehberg, Sebastian

FONTE

BioMed Central

RESUMO

In the current issue of Critical Care, Simon and coworkers investigated the effects of first-line arginine vasopressin (AVP) on organ function and systemic metabolism compared with norepinephrine in a pig model of fecal peritonitis. AVP was titrated according to the mean arterial pressure suggesting a vasopressor rather than a hormone replacement therapy. The study provides some evidence for the safety of this therapeutic approach. It needs to be determined whether AVP is most beneficial as a constant low-dose infusion to supplement norepinephrine or in higher doses than currently recommended to substitute norepinephrine. In addition, future studies are warranted to evaluate whether a first-line therapy of AVP is superior to a last-resort administration.

Documentos Relacionados

• Steroids in septic shock: the confusion continues
• Steroids in septic shock: the confusion continues – authors' response
• Cortisol replacement for severe sepsis and septic shock: what should I do?
• Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
• Assessment of Neutrophil Function in Patients with Septic Shock: Comparison of Methods